Free Trial

More results...

Filter by Content types
Regulatory databases
Regulatory reports
Market reports
News analysis
Filter by Geography
Africa
Asia
Australasia
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • United States DEA hearings begin on proposal to reschedule cannabis ...
  • Switzerland Basel extends cannabis pilot project and includes new products ...
  • Czech Republic Decree simplifying medical cannabis prescription process proposed ...
  • Brazil Anvisa puts review of medical cannabis regulation on agenda ...
  • Denmark Trial scheme to prescribe medical cannabis made permanent ...
  • Europe ECR proposes including cannabis in EU goal to be tobacco-free by 2040 ...
  • Philippines DDB and PDEA open to reclassifying cannabis as less dangerous ...
  • Costa Rica Court rules bill regulating recreational cannabis is unconstitutional ...
  • Australia Senate rejects Greens’ cannabis legalisation bill ...
  • Europe EU Parliament approves new Commission ...
  • Philippines Senator plans to bring CBD laws in line with international recommendations ...
  • New Zealand Medicinal Cannabis Agency verifies new cannabis flower for tea ...
View all
Regulatory reports in North America

A regulatory analysis of cannabis consumption lounges in the US

Written by Anthony Traurig | 21st November 2023

Many state governments are now offering an alternative to adults who wish to consume cannabis outside of their home. This report examines the regulation of these consumption spaces in states that have legalised recreational...

Canada: CBD and cannabis regulation, September 2023

Written by Lorenzo Guaragna | 22nd September 2023

This report provides detailed analysis of the regulatory framework in place in Canada for CBD and other cannabinoids, hemp, and cannabis (both recreational and medical) ...

US federal: CBD and cannabis regulation, August 2023

Written by Anthony Traurig | 30th August 2023

This report provides detailed analysis around the current regulatory framework in place on a federal level in the US for hemp, CBD, other cannabinoids as well medical and recreational cannabis ...

Global cannabinoid vape compliance guide

Written by Pablo Cano Trilla | 2nd December 2022

The cannabinoid vape compliance guide goes beyond the legality of cannabinoid-containing vaping products and provides regulatory information on how they can reach the market and thrive ...

2022 US cannabis ballot initiative tracker

Written by Anthony Traurig | 15th November 2022

This tracker outlines the ballot initiatives in the US that are likely to appear on ballot this November and will be updated periodically to keep the information up to date ...

What the cannabis scheduling review means for the US

Written by Anthony Traurig | 21st October 2022

US president Joe Biden has called for a scheduling review of cannabis. This report will examine the procedure, potential outcomes, and implications of this scheduling...

US regulatory trends on intoxicating hemp-derived cannabinoids

Written by Anthony Traurig | 21st June 2022

Intoxicating hemp-derived cannabinoids (IHDC) have been major disruptors in the CBD and legal cannabis sectors in the US for some time now. This report details and analyses recent developments in their regulation ...

Medical and recreational cannabis – a global overview

Written by CannIntelligence | 4th March 2022

CBD-Intel has compiled and classified regulatory data on medical and recreational cannabis in over 50 jurisdictions around the world. This report is accompanied by a detailed database outlining the regulatory situation in selected countries ...

Regulatory report: cannabis delivery in the US

Written by Anthony Traurig | 29th September 2021

This regulatory report examines which of the 36 US states that have legalised medical and/or recreational cannabis sales allow for home deliveries of cannabis products ...

Regulatory report: CBD as a dietary supplement in the US and EU

Written by CannIntelligence | 28th June 2021

As CBD grows in popularity, its regulatory status remains poorly defined. In this report CBD-Intel reviews the regulatory framework of dietary supplements and where CBD fits, or would fit, within that framework ...

Regulatory report: delta-8 THC in the US 

Written by Anthony Traurig | 19th May 2021

Delta-8 THC has emerged as the hottest new cannabinoid in the US market. This report examines federal law on delta-8, notes trends that are happening at state level, and discusses what the future may hold...

Regulatory report: Canada, February 2021

Written by Anthony Traurig | 8th February 2021

Canada permits the cultivation, production, distribution, and sale of hemp, cannabis, and products derived from them, but only by those licensed to do so by the government. This report offers a detailed overview of the...

CBD product labelling – a US state-by-state analysis

Written by Anthony Traurig | 14th January 2021

This report details the labelling requirements for CBD products of all US states that have enacted regulations and shows how manufacturers can create a versatile label to satisfy as many states' regulations as possible ...

Regulatory report: Florida, June 2020

Written by Berta Camps Bisbal | 15th June 2020

This report provides an up-to-date analysis of the current regulatory regime for CBD and hemp-related products in the US state of Florida ...

Regulatory report: Virginia, May 2020

Written by Berta Camps Bisbal | 7th May 2020

This report offers an overview of the regulatory landscape in the US state of Virginia, including information on cultivation, finished products and import/export...

Regulatory report: Oklahoma, April 2020

Written by Berta Camps Bisbal | 28th April 2020

This report offers an overview of the regulatory landscape in the US state of Oklahoma, including information on cultivation, finished products and import/export restrictions ...

Regulatory report: Mexico, April 2020

Written by CannIntelligence | 23rd April 2020

Cultivation and processing of hemp is currently not allowed in Mexico, however there have been recent proposals for legalisation. This report provides an overview of the current regulatory landscape, as well as likely future regulation...

Regulatory report: Texas snapshot, February 2020

Written by Berta Camps Bisbal | 25th February 2020

The regulatory snapshot gives a comprehensive overview of the current regulatory landscape in Texas, detailing import and export laws, rules around vaping, cosmetic and pet food products as well as foodstuffs ...

Florida regulatory snapshot, January 2020 (update)

Written by Berta Camps Bisbal | 11th February 2020

This report on Florida provides updated information on our last report from the end of year, specifying updates to regulation relating to seeds, foodstuffs and pet food ...

CBD and food products in the US: FAQs

Written by CannIntelligence | 29th January 2020

This report identifies and answers some of the most important questions surrounding the legality and regulation of CBD and food in the US ...

New York State regulatory snapshot, January 2020

Written by Berta Camps Bisbal | 1st January 2020

The approval of Senate Bill 6184, which will be effective on 8th March 2020, introduces a new licensing regime to New York State, changes the definition of industrial hemp, and provides other amendments to regulation...

Florida regulatory snapshot, December 2019

Written by Berta Camps Bisbal | 30th December 2019

While the bill legalising planting and growing in hemp has been enacted in Florida, planting hemp is not yet allowed. This report outlines current regulations, focusing on processing, import/export and permits, as well as extracts...

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.